Actelion

July 6, 2017
Global Drug Development IPOs: 27 IPOs Raise over $2.83B in Q2-2017

Global Therapeutic IPO Market on the Rise: 27 Companies Raise Over $2.83B in Q2 2017

[vc_row][vc_column][vc_column_text]   After a well-documented lull in 2016 and a sluggish start to 2017, the global therapeutic IPO market has started to bounce back in Q2, […]
January 31, 2017
What Assets are J&J Actually Getting with its $30B Acquisition of Actelion?

M&A Analysis: Is Johnson & Johnson’s $30B Acquisition of Actelion Overvalued?

[vc_row][vc_column][vc_column_text] Healthcare multinational Johnson & Johnson will pay $30B to acquire Swiss drugmaker Actelion in an all-cash deal. Under the conditions of the deal, Actelion will […]
Contact Us